Clinical Trial Update: Chidamide Plus CHOEP Combined With Upfront ASCT in Untreated Peripheral T-cell Lymphoma [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating chidamide with CHOEP chemotherapy and upfront autologous stem cell transplant in untreated peripheral T-cell lymphoma; the…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peripheral T-cell Lymphoma
• T-cell Non-hodgkin Lymphoma

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Chidamide (chidamide)
• Doxorubicin (doxorubicin)
• Etoposide (Etoposide)
• PREDNISONE (Prednisone)
• Vincristine (vincristine)

Snippet

Sponsor: Peking Union Medical College Hospital | Conditions: T Cell Non-Hodgkin's Lymphoma | Phase 1, Phase 2 | Status: UNKNOWN